Geistlich Pharma is the world market leader in regenerative dentistry, thanks to its dental regeneration products. The use of Geistlich Bio-Oss^® and Geistlich Bio-Gide^® for guided bone regeneration is now regarded as the established treatment for the reconstruction of bone and soft tissue. Following the successful registration of Geistlich Bio-Oss^® in 2012, the Japanese authorities have now also granted a licence to Geistlich Bio-Gide^®. This marks another milestone in Geistlich Pharma’s continuing geographic expansion strategy. Mario Mucha, COO of Geistlich Pharma AG, commented: “Japan is an extremely important market for us, as it has enormous potential. We are therefore really looking forward to supplying the Japanese dental profession with both products very soon”. Geistlich Bio-Gide^® will go on the market shortly; like Geistlich Bio-Oss^®, sales will be handled via our distribution partner Hakusui Trading Co.